175 related articles for article (PubMed ID: 15655319)
1. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis.
Arizono K; Nomura K; Motoyama T; Matsushita Y; Matsuoka K; Miyazu R; Takeshita H; Fukui H
Blood Purif; 2004; 22 Suppl 2():26-9. PubMed ID: 15655319
[TBL] [Abstract][Full Text] [Related]
2. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
[TBL] [Abstract][Full Text] [Related]
3. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
[TBL] [Abstract][Full Text] [Related]
4. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients.
Kwan BC; Chow KM; Ma TK; Cheng PM; Leung CB; Li PK; Szeto CC
Nephron Clin Pract; 2013; 123(3-4):246-53. PubMed ID: 24008429
[TBL] [Abstract][Full Text] [Related]
5. Ultrapure dialysate.
Ward RA
Semin Dial; 2004; 17(6):489-97. PubMed ID: 15660580
[TBL] [Abstract][Full Text] [Related]
6. Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis.
Susantitaphong P; Riella C; Jaber BL
Nephrol Dial Transplant; 2013 Feb; 28(2):438-46. PubMed ID: 23291370
[TBL] [Abstract][Full Text] [Related]
7. Ultrapure dialysate influences serum myeloperoxidase levels and lipid metabolism.
Honda H; Suzuki H; Hosaka N; Hirai Y; Sanada D; Nakamura M; Nagai H; Ashikaga E; Matsumoto K; Mukai M; Watanabe M; Akizawa T
Blood Purif; 2009; 28(1):29-39. PubMed ID: 19325237
[TBL] [Abstract][Full Text] [Related]
8. Ultrapure dialysate: facts and myths.
Bommer J; Jaber BL
Semin Dial; 2006; 19(2):115-9. PubMed ID: 16551288
[TBL] [Abstract][Full Text] [Related]
9. The effect of ultrapure dialysate on improving renal anemia.
Go I; Takemoto Y; Tsuchida K; Sugimura K; Nakatani T
Osaka City Med J; 2007 Jun; 53(1):17-23. PubMed ID: 17867630
[TBL] [Abstract][Full Text] [Related]
10. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
[TBL] [Abstract][Full Text] [Related]
11. Ultrapure dialysis fluid--direct and indirect benefits in dialysis therapy.
Ledebo I
Blood Purif; 2004; 22 Suppl 2():20-5. PubMed ID: 15655318
[TBL] [Abstract][Full Text] [Related]
12. Treatment of periodontal diseases reduces chronic systemic inflammation in maintenance hemodialysis patients.
Siribamrungwong M; Puangpanngam K
Ren Fail; 2012; 34(2):171-5. PubMed ID: 22229644
[TBL] [Abstract][Full Text] [Related]
13. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
[TBL] [Abstract][Full Text] [Related]
14. Use of ultrafiltered dialysate is associated with improvements in haemodialysis-associated morbidity in patients treated with reused dialysers.
Ouseph R; Jones S; Dhananjaya N; Ward RA
Nephrol Dial Transplant; 2007 Aug; 22(8):2269-75. PubMed ID: 17400564
[TBL] [Abstract][Full Text] [Related]
15. Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: a case report.
Gong D; Ji D; Zhang K; Huang X; Huang G; Xu B; Liu Z
Hemodial Int; 2013 Oct; 17(4):618-23. PubMed ID: 23113894
[TBL] [Abstract][Full Text] [Related]
16. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
17. Preparation of ultrapure dialysate in Japan--clinical usefulness and short-term future.
Sato T; Kurosawa A; Kurihara T; Kurosawa T
Blood Purif; 2004; 22 Suppl 2():55-9. PubMed ID: 15655325
[TBL] [Abstract][Full Text] [Related]
18. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
19. [Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients].
González AI; Brites F; Elbert A; Gómez-Rosso L; Berg G; Wikinski R; Schreier L
Medicina (B Aires); 2010; 70(6):508-12. PubMed ID: 21163737
[TBL] [Abstract][Full Text] [Related]
20. Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients.
Yamada K; Fujimoto S; Tokura T; Fukudome K; Ochiai H; Komatsu H; Sato Y; Hara S; Eto T
Ren Fail; 2005; 27(4):361-5. PubMed ID: 16060120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
